Oral contraceptives and menopausal hormone therapy as breast cancer risk categories
The research provided includes analysis of the current state of the problem on the use of oral contraceptives and menopausal hormone therapy. These therapeutic options were evaluated in terms of their importance for the risk of breast cancer. The possibility of using these drugs in a cohort of high-...
Main Authors: | I. V. Vуsotskaya, V. P. Letyagin, I. K. Vorotnikov, V. U. Kirsanov, I. A. Gladilina, E. A. Kim |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2019-09-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/647 |
Similar Items
-
Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer
by: A. V. Bykova, et al.
Published: (2014-07-01) -
Drug treatment for metastatic breast cancer
by: E. V. Artamonova
Published: (2014-08-01) -
Comparative analysis of the long-term results of treatment in patients with Stages I-IIa breast cancer in relation to major prognostic factors
by: Yu. V. Efimkina, et al.
Published: (2014-08-01) -
Present and future of breast cancer anti-Her-2-therapy
by: V. P. Letyagin
Published: (2014-07-01) -
Menopausal hormone therapy and heart disease prevention: desired or valid?
by: V. I. Podzolkov, et al.
Published: (2019-06-01)